Methods:A systematic search and review procedure was conducted of research reporting use and results of the PedsQL-TM with samples of pediatric heart, liver, kidney, and lung transplantation.Search terms selected were each (“Pediatric Quality of Life Inventory” AND “transplant module”) and (“PedsQL” AND “transplant module”). Searches were conducted in nine scholarly databases and two additional sources to identify potentially unpublished research. Using Covidence software for facilitation of systematic reviews, multiple reviewers screened and reviewed for studies meeting inclusion criteria in accordance with PRISMA guidelines.
Results: From 429 initially identified studies, a final sample of nine studies reported findings for the PedsQL-TM with pediatric organ transplant recipients. Most studies relied on either kidney or liver transplant recipients from single pediatric transplant centers. Factor validity of the PedsQL-TM and inter-rater reliability between patients and parents were found not to have been adequately determined with the only factor analyses reported in the original validation study and that of a Japanese translated version. Additionally, the exploratory factor analysis within the original validity study did not utilize recommended factor analytic methods. Internal consistency reliability was found as acceptable or excellent across multiple studies. PedsQL-TM scores were found to vary with other HRQOL issues, yet few studies examined their association with critical health outcomes such as medication adherence or organ rejection.
Conclusions and Implications: With the goal of enhancing and sustaining HRQOL in pediatric organ transplant recipients, the need for a psychometrically valid and reliable measure of transplant-specific HRQOL in children is apparent. Social workers on transplant teams in national pediatric transplant centers have increasingly focused on HRQOL as a consideration during posttransplant care and as a primary health outcome for these children. Research on the PedsQL-TM supports the promise of this measure although future efforts should be taken to examine measurement issues such as factor validity and IRR. Assessing transplant-specific HRQOL in these patients is paramount for their care and appropriate decision-making by patients, families, and the transplant team.